The trademark application NEUTROGENA was filed by Kenvue Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 5, 2021, and it was registered by office on July 13, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
A transfer of the trademark registration was recorded on February 21, 2024.